跳至主要内容
临床试验/CTRI/2021/05/033863
CTRI/2021/05/033863尚未招募不适用

A Pre-clinical and Clinical Study to evaluate the efficacy ofAshwagandhadi Avaleha as an Adjuvant in the management ofTuberculosis with Anti Tubercular Treatment.

Principal1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年1月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
Principal
入组人数
60
试验地点
1
主要终点
Efficacy of Ashwagandhadi Avaleha to reduce/prevent toxicity when administered as add on therapy

研究概览

简要总结

I would like to publish my trial after completion of the trial as soon as possible. Patients will be selected from OPD/IPD of R.G.G.P.G. Ayurvedic College & Hospital, Paprola.

Two groups  of 60 patients will be assessed to evaluate the efficacy of Ashwagandhadi Avaleha as an Adjuvant in management of Tuberculosis along with Anti Tubercular Treatment.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
15.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Freshly diagnosed cases of tuberculosis(Pulmonary Tuberculosis and Tubercular pleural effusion)
  • Patients of either sex between the age of 15-70 years.
  • Patients willing and able to participate for 8 weeks duration.

排除标准

  • MDR and XDR cases of tuberculosis.
  • Patient with uncontrolled hypertension.
  • Suffering from any other chronic infections including HIV.
  • Patients Below the age of 15yrs and above the age of 70yrs.
  • Patients not willing for trial.
  • Individuals who have completed participation in any other clinical trial during the past three months.
  • Any other condition which the Principal investigator thinks may jeopardize the study.

结局指标

主要结局

Efficacy of Ashwagandhadi Avaleha to reduce/prevent toxicity when administered as add on therapy

时间窗: 8 weeks

along with Anti tubercular drugs in the management of Tuberculosis

时间窗: 8 weeks

次要结局

  • Efficacy of the Ashwagandhadi Avaleha in improving general well being.(8 weeks)

研究者

发起方
Principal
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验